Covid-19 Impact on Global Pet Medicine Market Insights, Forecast to 2026

Covid-19 Impact on Global Pet Medicine Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Pet Medicine Product Introduction
1.2 Market Segments
1.3 Key Pet Medicine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Pet Medicine Market Size Growth Rate by Type
1.4.2 External Use
1.4.3 Internal Use
1.5 Market by Application
1.5.1 Global Pet Medicine Market Size Growth Rate by Application
1.5.2 Dogs
1.5.3 Cats
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Pet Medicine Industry Impact
1.6.1 How the Covid-19 is Affecting the Pet Medicine Industry
1.6.1.1 Pet Medicine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Pet Medicine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Pet Medicine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Pet Medicine Market Size Estimates and Forecasts
2.1.1 Global Pet Medicine Revenue 2015-2026
2.1.2 Global Pet Medicine Sales 2015-2026
2.2 Pet Medicine Market Size by Region: 2020 Versus 2026
2.2.1 Global Pet Medicine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Pet Medicine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Pet Medicine Competitor Landscape by Players
3.1 Pet Medicine Sales by Manufacturers
3.1.1 Pet Medicine Sales by Manufacturers (2015-2020)
3.1.2 Pet Medicine Sales Market Share by Manufacturers (2015-2020)
3.2 Pet Medicine Revenue by Manufacturers
3.2.1 Pet Medicine Revenue by Manufacturers (2015-2020)
3.2.2 Pet Medicine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Pet Medicine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Pet Medicine Revenue in 2019
3.2.5 Global Pet Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Pet Medicine Price by Manufacturers
3.4 Pet Medicine Manufacturing Base Distribution, Product Types
3.4.1 Pet Medicine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pet Medicine Product Type
3.4.3 Date of International Manufacturers Enter into Pet Medicine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Pet Medicine Market Size by Type (2015-2020)
4.1.1 Global Pet Medicine Sales by Type (2015-2020)
4.1.2 Global Pet Medicine Revenue by Type (2015-2020)
4.1.3 Pet Medicine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Pet Medicine Market Size Forecast by Type (2021-2026)
4.2.1 Global Pet Medicine Sales Forecast by Type (2021-2026)
4.2.2 Global Pet Medicine Revenue Forecast by Type (2021-2026)
4.2.3 Pet Medicine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Pet Medicine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Pet Medicine Market Size by Application (2015-2020)
5.1.1 Global Pet Medicine Sales by Application (2015-2020)
5.1.2 Global Pet Medicine Revenue by Application (2015-2020)
5.1.3 Pet Medicine Price by Application (2015-2020)
5.2 Pet Medicine Market Size Forecast by Application (2021-2026)
5.2.1 Global Pet Medicine Sales Forecast by Application (2021-2026)
5.2.2 Global Pet Medicine Revenue Forecast by Application (2021-2026)
5.2.3 Global Pet Medicine Price Forecast by Application (2021-2026)
6 North America
6.1 North America Pet Medicine by Country
6.1.1 North America Pet Medicine Sales by Country
6.1.2 North America Pet Medicine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Pet Medicine Market Facts & Figures by Type
6.3 North America Pet Medicine Market Facts & Figures by Application
7 Europe
7.1 Europe Pet Medicine by Country
7.1.1 Europe Pet Medicine Sales by Country
7.1.2 Europe Pet Medicine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pet Medicine Market Facts & Figures by Type
7.3 Europe Pet Medicine Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Pet Medicine by Region
8.1.1 Asia Pacific Pet Medicine Sales by Region
8.1.2 Asia Pacific Pet Medicine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Pet Medicine Market Facts & Figures by Type
8.3 Asia Pacific Pet Medicine Market Facts & Figures by Application
9 Latin America
9.1 Latin America Pet Medicine by Country
9.1.1 Latin America Pet Medicine Sales by Country
9.1.2 Latin America Pet Medicine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Pet Medicine Market Facts & Figures by Type
9.3 Central & South America Pet Medicine Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Pet Medicine by Country
10.1.1 Middle East and Africa Pet Medicine Sales by Country
10.1.2 Middle East and Africa Pet Medicine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Pet Medicine Market Facts & Figures by Type
10.3 Middle East and Africa Pet Medicine Market Facts & Figures by Application
11 Company Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Corporation Information
11.1.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
11.1.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Boehringer Ingelheim Pet Medicine Products Offered
11.1.5 Boehringer Ingelheim Recent Development
11.2 Zoetis
11.2.1 Zoetis Corporation Information
11.2.2 Zoetis Description, Business Overview and Total Revenue
11.2.3 Zoetis Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Zoetis Pet Medicine Products Offered
11.2.5 Zoetis Recent Development
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Description, Business Overview and Total Revenue
11.3.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Merck Pet Medicine Products Offered
11.3.5 Merck Recent Development
11.4 Elanco
11.4.1 Elanco Corporation Information
11.4.2 Elanco Description, Business Overview and Total Revenue
11.4.3 Elanco Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Elanco Pet Medicine Products Offered
11.4.5 Elanco Recent Development
11.5 Bayer
11.5.1 Bayer Corporation Information
11.5.2 Bayer Description, Business Overview and Total Revenue
11.5.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Bayer Pet Medicine Products Offered
11.5.5 Bayer Recent Development
11.6 Virbac
11.6.1 Virbac Corporation Information
11.6.2 Virbac Description, Business Overview and Total Revenue
11.6.3 Virbac Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Virbac Pet Medicine Products Offered
11.6.5 Virbac Recent Development
11.7 Ceva Sante Animale
11.7.1 Ceva Sante Animale Corporation Information
11.7.2 Ceva Sante Animale Description, Business Overview and Total Revenue
11.7.3 Ceva Sante Animale Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Ceva Sante Animale Pet Medicine Products Offered
11.7.5 Ceva Sante Animale Recent Development
11.8 Vetoquinol
11.8.1 Vetoquinol Corporation Information
11.8.2 Vetoquinol Description, Business Overview and Total Revenue
11.8.3 Vetoquinol Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Vetoquinol Pet Medicine Products Offered
11.8.5 Vetoquinol Recent Development
11.9 Bimeda Animal Health
11.9.1 Bimeda Animal Health Corporation Information
11.9.2 Bimeda Animal Health Description, Business Overview and Total Revenue
11.9.3 Bimeda Animal Health Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Bimeda Animal Health Pet Medicine Products Offered
11.9.5 Bimeda Animal Health Recent Development
11.10 Dechra Pharmaceuticals
11.10.1 Dechra Pharmaceuticals Corporation Information
11.10.2 Dechra Pharmaceuticals Description, Business Overview and Total Revenue
11.10.3 Dechra Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Dechra Pharmaceuticals Pet Medicine Products Offered
11.10.5 Dechra Pharmaceuticals Recent Development
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Corporation Information
11.1.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
11.1.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Boehringer Ingelheim Pet Medicine Products Offered
11.1.5 Boehringer Ingelheim Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Pet Medicine Market Estimates and Projections by Region
12.1.1 Global Pet Medicine Sales Forecast by Regions 2021-2026
12.1.2 Global Pet Medicine Revenue Forecast by Regions 2021-2026
12.2 North America Pet Medicine Market Size Forecast (2021-2026)
12.2.1 North America: Pet Medicine Sales Forecast (2021-2026)
12.2.2 North America: Pet Medicine Revenue Forecast (2021-2026)
12.2.3 North America: Pet Medicine Market Size Forecast by Country (2021-2026)
12.3 Europe Pet Medicine Market Size Forecast (2021-2026)
12.3.1 Europe: Pet Medicine Sales Forecast (2021-2026)
12.3.2 Europe: Pet Medicine Revenue Forecast (2021-2026)
12.3.3 Europe: Pet Medicine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Pet Medicine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Pet Medicine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Pet Medicine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Pet Medicine Market Size Forecast by Region (2021-2026)
12.5 Latin America Pet Medicine Market Size Forecast (2021-2026)
12.5.1 Latin America: Pet Medicine Sales Forecast (2021-2026)
12.5.2 Latin America: Pet Medicine Revenue Forecast (2021-2026)
12.5.3 Latin America: Pet Medicine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Pet Medicine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Pet Medicine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Pet Medicine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Pet Medicine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Pet Medicine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pet Medicine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables
Table 1. Pet Medicine Market Segments
Table 2. Ranking of Global Top Pet Medicine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Pet Medicine Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of External Use
Table 5. Major Manufacturers of Internal Use
Table 6. COVID-19 Impact Global Market: (Four Pet Medicine Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Pet Medicine Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Pet Medicine Players to Combat Covid-19 Impact
Table 11. Global Pet Medicine Market Size Growth Rate by Application 2020-2026 (MT)
Table 12. Global Pet Medicine Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 13. Global Pet Medicine Sales by Regions 2015-2020 (MT)
Table 14. Global Pet Medicine Sales Market Share by Regions (2015-2020)
Table 15. Global Pet Medicine Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Pet Medicine Sales by Manufacturers (2015-2020) (MT)
Table 17. Global Pet Medicine Sales Share by Manufacturers (2015-2020)
Table 18. Global Pet Medicine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Pet Medicine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pet Medicine as of 2019)
Table 20. Pet Medicine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Pet Medicine Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Pet Medicine Price (2015-2020) (USD/MT)
Table 23. Pet Medicine Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Pet Medicine Product Type
Table 25. Date of International Manufacturers Enter into Pet Medicine Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Pet Medicine Sales by Type (2015-2020) (MT)
Table 28. Global Pet Medicine Sales Share by Type (2015-2020)
Table 29. Global Pet Medicine Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Pet Medicine Revenue Share by Type (2015-2020)
Table 31. Pet Medicine Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 32. Global Pet Medicine Sales by Application (2015-2020) (MT)
Table 33. Global Pet Medicine Sales Share by Application (2015-2020)
Table 34. North America Pet Medicine Sales by Country (2015-2020) (MT)
Table 35. North America Pet Medicine Sales Market Share by Country (2015-2020)
Table 36. North America Pet Medicine Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Pet Medicine Revenue Market Share by Country (2015-2020)
Table 38. North America Pet Medicine Sales by Type (2015-2020) (MT)
Table 39. North America Pet Medicine Sales Market Share by Type (2015-2020)
Table 40. North America Pet Medicine Sales by Application (2015-2020) (MT)
Table 41. North America Pet Medicine Sales Market Share by Application (2015-2020)
Table 42. Europe Pet Medicine Sales by Country (2015-2020) (MT)
Table 43. Europe Pet Medicine Sales Market Share by Country (2015-2020)
Table 44. Europe Pet Medicine Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Pet Medicine Revenue Market Share by Country (2015-2020)
Table 46. Europe Pet Medicine Sales by Type (2015-2020) (MT)
Table 47. Europe Pet Medicine Sales Market Share by Type (2015-2020)
Table 48. Europe Pet Medicine Sales by Application (2015-2020) (MT)
Table 49. Europe Pet Medicine Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Pet Medicine Sales by Region (2015-2020) (MT)
Table 51. Asia Pacific Pet Medicine Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Pet Medicine Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Pet Medicine Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Pet Medicine Sales by Type (2015-2020) (MT)
Table 55. Asia Pacific Pet Medicine Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Pet Medicine Sales by Application (2015-2020) (MT)
Table 57. Asia Pacific Pet Medicine Sales Market Share by Application (2015-2020)
Table 58. Latin America Pet Medicine Sales by Country (2015-2020) (MT)
Table 59. Latin America Pet Medicine Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Pet Medicine Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Pet Medicine Revenue Market Share by Country (2015-2020)
Table 62. Latin America Pet Medicine Sales by Type (2015-2020) (MT)
Table 63. Latin America Pet Medicine Sales Market Share by Type (2015-2020)
Table 64. Latin America Pet Medicine Sales by Application (2015-2020) (MT)
Table 65. Latin America Pet Medicine Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Pet Medicine Sales by Country (2015-2020) (MT)
Table 67. Middle East and Africa Pet Medicine Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Pet Medicine Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Pet Medicine Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Pet Medicine Sales by Type (2015-2020) (MT)
Table 71. Middle East and Africa Pet Medicine Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Pet Medicine Sales by Application (2015-2020) (MT)
Table 73. Middle East and Africa Pet Medicine Sales Market Share by Application (2015-2020)
Table 74. Boehringer Ingelheim Corporation Information
Table 75. Boehringer Ingelheim Description and Major Businesses
Table 76. Boehringer Ingelheim Pet Medicine Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Boehringer Ingelheim Product
Table 78. Boehringer Ingelheim Recent Development
Table 79. Zoetis Corporation Information
Table 80. Zoetis Description and Major Businesses
Table 81. Zoetis Pet Medicine Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Zoetis Product
Table 83. Zoetis Recent Development
Table 84. Merck Corporation Information
Table 85. Merck Description and Major Businesses
Table 86. Merck Pet Medicine Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Merck Product
Table 88. Merck Recent Development
Table 89. Elanco Corporation Information
Table 90. Elanco Description and Major Businesses
Table 91. Elanco Pet Medicine Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Elanco Product
Table 93. Elanco Recent Development
Table 94. Bayer Corporation Information
Table 95. Bayer Description and Major Businesses
Table 96. Bayer Pet Medicine Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Bayer Product
Table 98. Bayer Recent Development
Table 99. Virbac Corporation Information
Table 100. Virbac Description and Major Businesses
Table 101. Virbac Pet Medicine Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Virbac Product
Table 103. Virbac Recent Development
Table 104. Ceva Sante Animale Corporation Information
Table 105. Ceva Sante Animale Description and Major Businesses
Table 106. Ceva Sante Animale Pet Medicine Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Ceva Sante Animale Product
Table 108. Ceva Sante Animale Recent Development
Table 109. Vetoquinol Corporation Information
Table 110. Vetoquinol Description and Major Businesses
Table 111. Vetoquinol Pet Medicine Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Vetoquinol Product
Table 113. Vetoquinol Recent Development
Table 114. Bimeda Animal Health Corporation Information
Table 115. Bimeda Animal Health Description and Major Businesses
Table 116. Bimeda Animal Health Pet Medicine Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Bimeda Animal Health Product
Table 118. Bimeda Animal Health Recent Development
Table 119. Dechra Pharmaceuticals Corporation Information
Table 120. Dechra Pharmaceuticals Description and Major Businesses
Table 121. Dechra Pharmaceuticals Pet Medicine Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. Dechra Pharmaceuticals Product
Table 123. Dechra Pharmaceuticals Recent Development
Table 124. Global Pet Medicine Sales Forecast by Regions (2021-2026) (MT)
Table 125. Global Pet Medicine Sales Market Share Forecast by Regions (2021-2026)
Table 126. Global Pet Medicine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 127. Global Pet Medicine Revenue Market Share Forecast by Regions (2021-2026)
Table 128. North America: Pet Medicine Sales Forecast by Country (2021-2026) (MT)
Table 129. North America: Pet Medicine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Europe: Pet Medicine Sales Forecast by Country (2021-2026) (MT)
Table 131. Europe: Pet Medicine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Asia Pacific: Pet Medicine Sales Forecast by Region (2021-2026) (MT)
Table 133. Asia Pacific: Pet Medicine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 134. Latin America: Pet Medicine Sales Forecast by Country (2021-2026) (MT)
Table 135. Latin America: Pet Medicine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Middle East and Africa: Pet Medicine Sales Forecast by Country (2021-2026) (MT)
Table 137. Middle East and Africa: Pet Medicine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 139. Key Challenges
Table 140. Market Risks
Table 141. Main Points Interviewed from Key Pet Medicine Players
Table 142. Pet Medicine Customers List
Table 143. Pet Medicine Distributors List
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Pet Medicine Product Picture
Figure 2. Global Pet Medicine Sales Market Share by Type in 2020 & 2026
Figure 3. External Use Product Picture
Figure 4. Internal Use Product Picture
Figure 5. Global Pet Medicine Sales Market Share by Application in 2020 & 2026
Figure 6. Dogs
Figure 7. Cats
Figure 8. Other
Figure 9. Pet Medicine Report Years Considered
Figure 10. Global Pet Medicine Market Size 2015-2026 (US$ Million)
Figure 11. Global Pet Medicine Sales 2015-2026 (MT)
Figure 12. Global Pet Medicine Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Pet Medicine Sales Market Share by Region (2015-2020)
Figure 14. Global Pet Medicine Sales Market Share by Region in 2019
Figure 15. Global Pet Medicine Revenue Market Share by Region (2015-2020)
Figure 16. Global Pet Medicine Revenue Market Share by Region in 2019
Figure 17. Global Pet Medicine Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Pet Medicine Revenue in 2019
Figure 19. Pet Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Pet Medicine Sales Market Share by Type (2015-2020)
Figure 21. Global Pet Medicine Sales Market Share by Type in 2019
Figure 22. Global Pet Medicine Revenue Market Share by Type (2015-2020)
Figure 23. Global Pet Medicine Revenue Market Share by Type in 2019
Figure 24. Global Pet Medicine Market Share by Price Range (2015-2020)
Figure 25. Global Pet Medicine Sales Market Share by Application (2015-2020)
Figure 26. Global Pet Medicine Sales Market Share by Application in 2019
Figure 27. Global Pet Medicine Revenue Market Share by Application (2015-2020)
Figure 28. Global Pet Medicine Revenue Market Share by Application in 2019
Figure 29. North America Pet Medicine Sales Growth Rate 2015-2020 (MT)
Figure 30. North America Pet Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Pet Medicine Sales Market Share by Country in 2019
Figure 32. North America Pet Medicine Revenue Market Share by Country in 2019
Figure 33. U.S. Pet Medicine Sales Growth Rate (2015-2020) (MT)
Figure 34. U.S. Pet Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Pet Medicine Sales Growth Rate (2015-2020) (MT)
Figure 36. Canada Pet Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Pet Medicine Market Share by Type in 2019
Figure 38. North America Pet Medicine Market Share by Application in 2019
Figure 39. Europe Pet Medicine Sales Growth Rate 2015-2020 (MT)
Figure 40. Europe Pet Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Pet Medicine Sales Market Share by Country in 2019
Figure 42. Europe Pet Medicine Revenue Market Share by Country in 2019
Figure 43. Germany Pet Medicine Sales Growth Rate (2015-2020) (MT)
Figure 44. Germany Pet Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Pet Medicine Sales Growth Rate (2015-2020) (MT)
Figure 46. France Pet Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Pet Medicine Sales Growth Rate (2015-2020) (MT)
Figure 48. U.K. Pet Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Pet Medicine Sales Growth Rate (2015-2020) (MT)
Figure 50. Italy Pet Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Pet Medicine Sales Growth Rate (2015-2020) (MT)
Figure 52. Russia Pet Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Pet Medicine Market Share by Type in 2019
Figure 54. Europe Pet Medicine Market Share by Application in 2019
Figure 55. Asia Pacific Pet Medicine Sales Growth Rate 2015-2020 (MT)
Figure 56. Asia Pacific Pet Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Pet Medicine Sales Market Share by Region in 2019
Figure 58. Asia Pacific Pet Medicine Revenue Market Share by Region in 2019
Figure 59. China Pet Medicine Sales Growth Rate (2015-2020) (MT)
Figure 60. China Pet Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Pet Medicine Sales Growth Rate (2015-2020) (MT)
Figure 62. Japan Pet Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Pet Medicine Sales Growth Rate (2015-2020) (MT)
Figure 64. South Korea Pet Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Pet Medicine Sales Growth Rate (2015-2020) (MT)
Figure 66. India Pet Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Pet Medicine Sales Growth Rate (2015-2020) (MT)
Figure 68. Australia Pet Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Pet Medicine Sales Growth Rate (2015-2020) (MT)
Figure 70. Taiwan Pet Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Pet Medicine Sales Growth Rate (2015-2020) (MT)
Figure 72. Indonesia Pet Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Pet Medicine Sales Growth Rate (2015-2020) (MT)
Figure 74. Thailand Pet Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Pet Medicine Sales Growth Rate (2015-2020) (MT)
Figure 76. Malaysia Pet Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Pet Medicine Sales Growth Rate (2015-2020) (MT)
Figure 78. Philippines Pet Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Pet Medicine Sales Growth Rate (2015-2020) (MT)
Figure 80. Vietnam Pet Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Pet Medicine Market Share by Type in 2019
Figure 82. Asia Pacific Pet Medicine Market Share by Application in 2019
Figure 83. Latin America Pet Medicine Sales Growth Rate 2015-2020 (MT)
Figure 84. Latin America Pet Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Pet Medicine Sales Market Share by Country in 2019
Figure 86. Latin America Pet Medicine Revenue Market Share by Country in 2019
Figure 87. Mexico Pet Medicine Sales Growth Rate (2015-2020) (MT)
Figure 88. Mexico Pet Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Pet Medicine Sales Growth Rate (2015-2020) (MT)
Figure 90. Brazil Pet Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Pet Medicine Sales Growth Rate (2015-2020) (MT)
Figure 92. Argentina Pet Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Pet Medicine Market Share by Type in 2019
Figure 94. Latin America Pet Medicine Market Share by Application in 2019
Figure 95. Middle East and Africa Pet Medicine Sales Growth Rate 2015-2020 (MT)
Figure 96. Middle East and Africa Pet Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Pet Medicine Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Pet Medicine Revenue Market Share by Country in 2019
Figure 99. Turkey Pet Medicine Sales Growth Rate (2015-2020) (MT)
Figure 100. Turkey Pet Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Pet Medicine Sales Growth Rate (2015-2020) (MT)
Figure 102. Saudi Arabia Pet Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Pet Medicine Sales Growth Rate (2015-2020) (MT)
Figure 104. U.A.E Pet Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Pet Medicine Market Share by Type in 2019
Figure 106. Middle East and Africa Pet Medicine Market Share by Application in 2019
Figure 107. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Zoetis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Elanco Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Virbac Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Ceva Sante Animale Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Vetoquinol Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Bimeda Animal Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Dechra Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. North America Pet Medicine Sales Growth Rate Forecast (2021-2026) (MT)
Figure 118. North America Pet Medicine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Europe Pet Medicine Sales Growth Rate Forecast (2021-2026) (MT)
Figure 120. Europe Pet Medicine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Asia Pacific Pet Medicine Sales Growth Rate Forecast (2021-2026) (MT)
Figure 122. Asia Pacific Pet Medicine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Latin America Pet Medicine Sales Growth Rate Forecast (2021-2026) (MT)
Figure 124. Latin America Pet Medicine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Middle East and Africa Pet Medicine Sales Growth Rate Forecast (2021-2026) (MT)
Figure 126. Middle East and Africa Pet Medicine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Porter's Five Forces Analysis
Figure 128. Channels of Distribution
Figure 129. Distributors Profiles
Figure 130. Bottom-up and Top-down Approaches for This Report
Figure 131. Data Triangulation
Figure 132. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs